Literature DB >> 22287381

Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.

Toru Baba1, Akio Kikuchi, Kazumi Hirayama, Yoshiyuki Nishio, Yoshiyuki Hosokai, Shigenori Kanno, Takafumi Hasegawa, Naoto Sugeno, Masatoshi Konno, Kyoko Suzuki, Shoki Takahashi, Hiroshi Fukuda, Masashi Aoki, Yasuto Itoyama, Etsuro Mori, Atsushi Takeda.   

Abstract

Dementia is one of the most debilitating symptoms of Parkinson's disease. A recent longitudinal study suggests that up to 80% of patients with Parkinson's disease will eventually develop dementia. Despite its clinical importance, the development of dementia is still difficult to predict at early stages. We previously identified olfactory dysfunction as one of the most important indicators of cortical hypometabolism in Parkinson's disease. In this study, we investigated the possible associations between olfactory dysfunction and the risk of developing dementia within a 3-year observation period. Forty-four patients with Parkinson's disease without dementia underwent the odour stick identification test for Japanese, memory and visuoperceptual assessments, (18)F-fluorodeoxyglucose positron emission tomography scans and magnetic resonance imaging scans at baseline and 3 years later. A subgroup of patients with Parkinson's disease who exhibited severe hyposmia at baseline showed more pronounced cognitive decline at the follow-up survey. By the end of the study, 10 of 44 patients with Parkinson's disease had developed dementia, all of whom had severe hyposmia at baseline. The multivariate logistic analysis identified severe hyposmia and visuoperceptual impairment as independent risk factors for subsequent dementia within 3 years. The patients with severe hyposmia had an 18.7-fold increase in their risk of dementia for each 1 SD (2.8) decrease in the score of odour stick identification test for Japanese. We also found an association between severe hyposmia and a characteristic distribution of cerebral metabolic decline, which was identical to that of dementia associated with Parkinson's disease. Furthermore, volumetric magnetic resonance imaging analyses demonstrated close relationships between olfactory dysfunction and the atrophy of focal brain structures, including the amygdala and other limbic structures. Together, our findings suggest that brain regions related to olfactory function are closely associated with cognitive decline and that severe hyposmia is a prominent clinical feature that predicts the subsequent development of Parkinson's disease dementia.

Entities:  

Mesh:

Year:  2012        PMID: 22287381     DOI: 10.1093/brain/awr321

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  81 in total

1.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

2.  Olfactory performance and resting state functional connectivity in non-demented drug naïve patients with Parkinson's disease.

Authors:  Mun Kyung Sunwoo; Jungho Cha; Jee Hyun Ham; Sook K Song; Jin Yong Hong; Jong-Min Lee; Young H Sohn; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2014-12-30       Impact factor: 5.038

Review 3.  [Translational research in geriatrics? A plea based on current biomedical key publications].

Authors:  L C Bollheimer; D Volkert; T Bertsch; J Bauer; J Klucken; C C Sieber; R Büttner
Journal:  Z Gerontol Geriatr       Date:  2013-08       Impact factor: 1.281

4.  Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

5.  Course of psychiatric symptoms and global cognition in early Parkinson disease.

Authors:  Patricia de la Riva; Kara Smith; Sharon X Xie; Daniel Weintraub
Journal:  Neurology       Date:  2014-08-15       Impact factor: 9.910

6.  Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment.

Authors:  Carlo Tessa; Claudio Lucetti; Marco Giannelli; Stefano Diciotti; Michele Poletti; Sabrina Danti; Filippo Baldacci; Claudio Vignali; Ubaldo Bonuccelli; Mario Mascalchi; Nicola Toschi
Journal:  Hum Brain Mapp       Date:  2014-01-22       Impact factor: 5.038

Review 7.  What can biomarkers tell us about cognition in Parkinson's disease?

Authors:  Brit Mollenhauer; Lynn Rochester; Alice Chen-Plotkin; David Brooks
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

8.  Olfactory impairment predicts cognitive decline in early Parkinson's disease.

Authors:  Michelle E Fullard; Baochan Tran; Lama M Chahine; James F Morley; Sharon X Xie; Jon B Toledo; Christi Scordia; Carly Linder; Rachael Purri; Daniel Weintraub; John E Duda
Journal:  Parkinsonism Relat Disord       Date:  2016-02-19       Impact factor: 4.891

9.  Influence of Olfactory Function on Appetite and Nutritional Status in the Elderly Requiring Nursing Care.

Authors:  E Arikawa; N Kaneko; K Nohara; T Yamaguchi; M Mitsuyama; T Sakai
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

Review 10.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.